Checkpoint Therapeutics I... (CKPT)

NASDAQ: CKPT · Real-Time Price · USD

4.13

0.01 (0.24%)

At close: May 02, 2025, 3:59 PM

4.12

-0.12%

After-hours: May 02, 2025, 04:05 PM EDT

Checkpoint Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	6.6M	4.93M	12.07M	54.73M	40.77M	26.08M	22M	19.23M	35.09M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	n/a	n/a	73K	17K	20K	26K	1.53M	331K	821K
Inventory	n/a	n/a	1.00	n/a	1.00	1.00	n/a	1.00	n/a
Other Current Assets	867K	450K	1.15M	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	7.47M	5.38M	13.29M	55.73M	42.6M	26.97M	24.9M	21.41M	35.98M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Assets	7.47M	5.38M	13.29M	55.73M	42.6M	26.97M	24.9M	21.41M	35.98M
Account Payables	6.09M	6.57M	11.54M	16.14M	3.44M	3.08M	9.75M	3.65M	2.47M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	11.57M	711K	11.45M	233K	385K	268K	377K	246K	213K
Total Current Liabilities	20.1M	18.43M	32.77M	25.98M	7.22M	8.12M	13.09M	6.37M	3.67M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	20.3M	n/a	n/a	n/a	n/a	n/a	n/a
Total Liabilities	20.1M	18.43M	32.77M	25.98M	7.22M	8.12M	13.09M	6.37M	3.67M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	5K	3K	1K	9K	7K	6K	4K	3K	3K
Retained Earnings	-370.57M	-314.33M	-262.49M	-199.86M	-143.19M	-120.11M	-95.4M	-59.03M	-36.35M
Comprehensive Income	n/a	n/a	1.88M	6.6M	4.62M	2.51M	1.75M	2.3M	3.92M
Shareholders Equity	-12.63M	-13.05M	-19.48M	29.75M	35.38M	18.85M	11.81M	15.04M	32.3M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a